![](/img/cover-not-exists.png)
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
Shi, Yuankai, Su, Hang, Song, Yongping, Jiang, Wenqi, Sun, Xiuhua, Qian, Wenbin, Zhang, Wei, Gao, Yuhuan, Jin, Zhengming, Zhou, Jianfeng, Jin, Chuan, Zou, Liqun, Qiu, Lugui, Li, Wei, Yang, Jianmin, HoVolume:
54
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2020.102731
Date:
April, 2020
File:
PDF, 2.93 MB
2020